Add-on therapy with doxazosin in patients with hypertension influences arterial stiffness and albuterol-mediated arterial vasodilation

British Journal of Clinical Pharmacology

Volumn 64, Issue 6, 2007, Pages 792-795

  Wykretowicz, Andrzej ^a   Guzik, Przemyslaw ^a   Krauze, Tomasz ^a   Adamska, Karolina ^a   Milewska, Agata ^a   Wysocki, Henryk ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

ACE inhibitors; Arterial stiffness; Doxazosin; Endothelial dysfunction

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; SALBUTAMOL;

ADD ON THERAPY; ADULT; ARTERY DILATATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RIGIDITY; SUSTAINED RELEASE PREPARATION; SYSTOLIC BLOOD PRESSURE;

ALBUTEROL; DELAYED-ACTION PREPARATIONS; DOXAZOSIN; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; MIDDLE AGED; VASCULAR RESISTANCE; VASODILATION;

EID: 36849063216     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02980.x     Document Type: Article

References (12)

1. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005 46 : 1118 22.
2. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004 44 : 248 52.
3. Millasseau SC, Kelly RP, Ritter JM, Chowienczyk PJ. Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin Sci (Lond) 2002 103 : 371 7.
4. Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC, Andersson TLG, Gosling RG, Ritter JM, Anggard EE. Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol 1999 34 : 2007 14.
5. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, Shu YE, MacKay LS, Webb DJ, Cockcroft JR. Pulse-wave analysis clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002 22 : 147 52.
6. Black HR. Doxazosin as combination therapy for patients with stage 1 and stage 2 hypertension. J Cardiovasc Pharmacol 2003 41 : 866 9.
7. Campo C, Segura J, Roldan C, Alcazar JM, Rodicio JL, Ruilope LM. Doxazosin GITS versus hydrochlorothiazide as add-on therapy in patients with uncontrolled hypertension. Blood Press Suppl 2003 2 16 21.
8. Van Bortel HL, Struijker-Boudier AJ, Safar ME. Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 2001 38 : 914 21.
9. Furberg CD. Doxazosin, an inferior antihypertensive agent? J Hum Hypertens 2002 16 : 375 7.
10. Takata Y, Yoshizumi T, Ito Y, Hirota Y, Fujishima M. Effect of administration and withdrawal of doxazosin on ambulatory blood pressure in patients with essential hypertension. Angiology 1995 46 : 11 8.
11. de Alvaro F, Hernandez-Presa MA ASOCIA Study. Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study. J Cardiovasc Pharmacol 2006 47 : 271 6.
12. Brude IR, Drevon CA, Viken K, Arnstad JE, Valnes KN, Nenseter MS. Doxazosin treatment and peroxidation of low-density lipoprotein among male hypertensive subjects: in vitro and ex vivo studies. Biochem Pharmacol 1999 58 : 183 91.